Olivier Bernard height - How tall is Olivier Bernard?

In March 2019, Bernard was targeted by an intimidation and doxing campaign from groups supporting the use of vitamin C injections as a treatment for cancer, after demonstrating this practice promoted by alternative medicine practitioners is not supported by scientific evidence. He publicly denounced the degree of hostility unleashed on him and his spouse.

2019: John Maddox Prize (early career award) for defending science (award from Nature and Sense About Science)

2018: Prix Coup de Coeur, ASPQ (award from Quebec's Public Health Association).

In 2017, his French Facebook page had 144,000 subscribers. The lepharmachien.com website logged 350,000 visits per month.

2015: Prix Innovation, Ordre des pharmaciens du Québec (Innovation Award from the Order of Pharmacists of Quebec).

2014: Prix Sceptique, Les sceptiques du Québec (award from Quebec's Skeptics Association).

Disillusioned by the industry's business practices, Bernard quit in 2013. He still works as a part-time pharmacist as he makes a name for himself as a scientific communicator, writes books, produces a television program and gives conferences.

He's been sharing his comments on medicine and pseudoscience on lepharmachien.com (in French) since 2012 and in English on theharmafist.com, since 2016. Bernard uses a colourful style, described by emergency physician Alain Vadeboncoeur as "friendly, but confident, perhaps a little of a smart-ass", but "he does not attack people, only practices, ideas and concepts." As a science communicator, Bernard says he's influenced by Vadeboncoeur, as well as astrophysicists Hubert Reeves and Neil deGrasse Tyson.

Bernard is from Beauport, which is now a borough of Quebec City. He has been living in Montreal since 2006. He is in a relationship with author India Desjardins. In Winter 2017, Bernard shared with university magazine Contact that starting a family is not out of the question.

Bernard started working as a pharmacist upon receiving his B.Pharm. in 2004 from Université Laval in Quebec City. He subsequently completed, in 2006, a master's degree in pharmacogenetics and worked for some time in the pharmaceutical industry.